6 days ago · Novel Drug Approvals for 2025 What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U.S.

Dec 15, 2025 · Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.

From July to September 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients with a variety of cancers.

Dec 10, 2025 · The FDA also granted traditional approval to epcoritamab as monotherapy for relapsed or refractory follicular lymphoma after two or more lines of systemic therapy. November 18, 2025.

Nov 3, 2025 · In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid …

Dec 16, 2025 · From powerful new drugs for lung and breast cancer to groundbreaking options for tough-to-treat blood cancers, this year’s approvals offer fresh hope and more personalized treatment …

Apr 14, 2025 · This article includes detailed information about drugs approved by the FDA for oncology indications in 2025.

October 2025 saw key FDA approvals and designations, expanding treatment options for solid tumors and hematologic malignancies. New combination therapies and adjuvant treatments were approved …

Jun 18, 2025 · In the first half of 2025, the FDA approved 7 novel drugs for oncologic conditions, including for non-small cell lung cancer; ovarian cancer; and metastatic, hormone receptor-positive, …

1 day ago · FDA immunotherapy approvals in 2025 reflect a major shift in cancer care, expanding immune-based treatments into earlier disease settings, perioperative strategies, and next-generation …